Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ERYP

ERYTECH Pharma (ERYP) Stock Price, News & Analysis

ERYTECH Pharma logo

About ERYTECH Pharma Stock (NASDAQ:ERYP)

Key Stats

Today's Range
$3.10
$3.10
50-Day Range
$4.19
$5.08
52-Week Range
$0.30
$1.47
Volume
N/A
Average Volume
93,510 shs
Market Capitalization
$105.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ERYP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ERYTECH Pharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ERYP Stock News Headlines

Royalty Pharma PLC Class A RPRX
If You Keep Cash In A U.S. Bank Account… Read This NOW
The Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of customer deposits as Americans rush into a new form of money… That’s just been authorized under President Trump’s highly controversial new law, S.1582.tc pixel
See More Headlines

ERYP Stock Analysis - Frequently Asked Questions

ERYTECH Pharma (ERYP) raised $125 million in an initial public offering (IPO) on Friday, November 10th 2017. The company issued 5,300,000 shares at $23.00-$24.00 per share. Jefferies, Cowen and Oddo BHF served as the underwriters for the IPO and JMP Securities was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that ERYTECH Pharma investors own include Ardelyx (ARDX), Idera Pharmaceuticals (IDRA), ImmunoGen (IMGN), Pfizer (PFE), Sesen Bio (SESN), Nymox Pharmaceutical (NYMX) and ObsEva (OBSV).

Company Calendar

Today
10/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:ERYP
CIK
1624422
Employees
49
Year Founded
2004

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.32
Current Ratio
3.65
Quick Ratio
3.65

Sales & Book Value

Annual Sales
$32.66 million
Price / Sales
3.24
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.80 per share
Price / Book
3.88

Miscellaneous

Outstanding Shares
34,120,000
Free Float
33,458,000
Market Cap
$105.77 million
Optionable
Not Optionable
Beta
2.69

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:ERYP) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners